Speech-Language Pathologists in Ontario, OH Accepting Medicare

29 Speech-Language Pathologists found. Showing 1 - 20

Mrs. Valeri Lyn Hairston, MA-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 890 W 4th St, Ontario, OH 44906 Phone: 419-774-5556

Ms. Rita Wallace Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 890 W 4th St, Ontario, OH 44906 Phone: 419-774-5520

Mrs. Cynthia Nell Nichols, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 890 W 4th St, Suite 100, Ontario, OH 44906 Phone: 419-774-5520

Christine Louise Johnson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2003 W 4th St Ste 205, Ontario, OH 44906 Phone: 615-355-8386    Fax: 419-529-3515

Mr. Peter Dering Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 890 W 4th St, Ontario, OH 44906 Phone: 419-774-5520    Fax: 419-774-5523

Jennifer Arnold Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 890 W 4th St, Ontario, OH 44906 Phone: 419-774-5520

Mary Lofreso Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2003 W 4th St Ste 205, Ontario, OH 44906 Phone: 567-307-6008

Lynn Kneile Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 890 W 4th St, Ontario, OH 44906 Phone: 419-774-5520

Miss Courtney Jean Kalman, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 890 W 4th St, Ontario, OH 44906 Phone: 419-774-5520

Megan R. Hancovsky, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2003 W 4th St, Ontario, OH 44906 Phone: 567-307-6008

Jennifer Plante, MACCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 890 W 4th St, Ontario, OH 44906 Phone: 419-774-5520

Allison Marie Hartman Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 890 W 4th St, Ontario, OH 44906 Phone: 419-774-5520

Megan Farver, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 890 W 4th St, Ontario, OH 44906 Phone: 419-774-5520

Suzanne Das, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 890 W 4th St, Suite 100, Ontario, OH 44906 Phone: 419-774-5520

Miss Mackenzie Utz, MA, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 890 W 4th St, Ontario, OH 44906 Phone: 419-774-5520

Kristin Hupp Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 241 Glenview Dr, Ontario, OH 44906 Phone: 740-817-4179

Elizabeth Emily Collins Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2003 W 4th St, Ontario, OH 44906 Phone: 567-307-6008

Julienne Bohrer, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2003 W 4th St, Ontario, OH 44906 Phone: 567-307-6008

Brandy Horvath, M.A. CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 457 Shelby Ontario Rd, Ontario, OH 44906 Phone: 419-747-4311

Reilly Harrington, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2003 W 4th St Ste 205, Ontario, OH 44906 Phone: 567-307-6008

News Archive

ViewRay's radiotherapy treatment planning and delivery software receives FDA marketing clearance

ViewRay™, Inc., a privately held medical device company, has received U.S. FDA marketing clearance for its radiotherapy treatment planning and delivery software.

Oramed Pharmaceuticals' ORMD-0801 Phase 2a study meets primary and secondary endpoints

Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, announced today results from its Phase 2a clinical trial for its ORMD-0801 oral insulin capsule for the treatment of type 2 diabetes. The trial was conducted under a United States Food and Drug Administration IND (Investigational New Drug) protocol. The Phase 2a study met all primary and secondary endpoints.

BioMed Central launches new journal BMC Sports Science, Medicine and Rehabilitation

Open access publisher BioMed Central is proud to announce the launch of BMC Sports Science, Medicine and Rehabilitation, another addition to the BMC-series portfolio.

FDA accepts DBV Technologies' IND for clinical study of VIASKIN for desensitization to peanut allergy

DBV Technologies (DBV), a biotech company specializing in food allergy with innovative products for diagnosis and treatment, announced today the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application. DBV Technologies will begin clinical investigation of its lead food allergy desensitization candidate, VIASKIN® PEANUT, for the desensitization to peanut allergy. The Company expects to commence recruitment of peanut allergy patients at several medical centers in the U.S. this month.

Birch bark compound may be potent prostate cancer fighter

A compound found in the bark of the white birch tree - betulonic acid, a derivative of betulinol - may finally have been rendered a water-soluble, bio-available drug, and is already showing the potential to be a possible agent against prostate cancer - in cell culture and in an animal model.

Read more Medical News

› Verified 1 days ago

• 1(current)
• 2